Company news

AdAlta Ltd. news in 2022

AdAlta Ltd.'s news releases, calls and decks from 2022, newest first.

View company

AD-214 progress and priorities webinar presentation

November 1, 2022

AD-214 progress and priorities

November 1, 2022

Balance of R&D Tax Incentive Refund received

October 26, 2022

1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer

October 12, 2022

R&D Tax Incentive Refund received

October 3, 2022

Quarterly Appendix 4C and Activities Report

July 24, 2022

AD-214 program update, cash runway extension

July 3, 2022

European Patent for AD-214 granted

June 13, 2022

BIO International Convention presentation

May 31, 2022

AdAlta presentation at Bioshares Biotech Summit

May 9, 2022

Indian patent for AD-214

April 6, 2022

Inhaled AD-214 preclinical program

April 4, 2022

PAC Partners Healthcare Conference - Corporate Presentation

April 4, 2022

$1.6M Second Tranche R&D Cash Flow Loan Received

March 8, 2022

Chinese patent granted for AD-214

March 1, 2022

Change in Director Interest Notice x 4

February 10, 2022

Application for quotation of securities - 1AD

February 6, 2022

Entitlement Offer Results

February 3, 2022

Presentation to Share Cafe Webinar

January 19, 2022

Presentation Conference Schedule - January 2022

January 3, 2022

Decks in 2022